Asano M, Masuzawa K, Matsuda T, Asano T
Department of Pharmacology, Nagoya City University Medical School, Japan.
J Hypertens. 1991 Jul;9(7):607-13. doi: 10.1097/00004872-199107000-00005.
Beta-adrenoceptors in femoral and mesenteric arteries from 13-week-old spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats were studied using radioligand binding assays and were compared with in vitro measurements of beta-adrenoceptor-mediated relaxation. The relaxant responses to noradrenaline via beta-adrenoceptors were significantly decreased in the SHR femoral artery when compared with the WKY femoral artery. However, under the same conditions, arterial relaxant responses to forskolin, an activator of adenylate cyclase, were not significantly different between SHR and WKY rats. Specific binding of 125I-iodocyanopindolol to membranes prepared from femoral arteries of SHR and WKY rats was saturable and of high affinity. Neither the equilibrium dissociation constant of 125I-iodocyanopindolol, nor the maximum number of binding sites were significantly different between SHR and WKY rats. Similar results were obtained in the case of mesenteric arteries from SHR and WKY rats. These results indicate that the decreased responsiveness to beta-adrenoceptor stimulation in SHR arteries is not associated with alterations in beta-adrenoceptors and further support the hypothesis that a reduced function of the stimulatory guanosine triphosphate-binding protein is responsible for the decreased responsiveness to a variety of receptor agonists whose mechanism of action involves adenylate cyclase activation.
采用放射性配体结合分析法,对13周龄自发性高血压大鼠(SHR)和正常血压的Wistar - Kyoto(WKY)大鼠股动脉和肠系膜动脉中的β - 肾上腺素能受体进行了研究,并与β - 肾上腺素能受体介导的舒张功能的体外测量结果进行了比较。与WKY大鼠股动脉相比,SHR大鼠股动脉中通过β - 肾上腺素能受体对去甲肾上腺素的舒张反应显著降低。然而,在相同条件下,SHR大鼠和WKY大鼠对腺苷酸环化酶激活剂福斯高林的动脉舒张反应并无显著差异。125I - 碘氰吲哚洛尔与SHR大鼠和WKY大鼠股动脉制备的膜的特异性结合是可饱和的且具有高亲和力。SHR大鼠和WKY大鼠之间,125I - 碘氰吲哚洛尔的平衡解离常数和最大结合位点数均无显著差异。SHR大鼠和WKY大鼠肠系膜动脉也得到了类似结果。这些结果表明,SHR大鼠动脉对β - 肾上腺素能受体刺激反应性降低与β - 肾上腺素能受体的改变无关,并进一步支持了以下假说:刺激性鸟苷三磷酸结合蛋白功能降低是导致对多种其作用机制涉及腺苷酸环化酶激活的受体激动剂反应性降低的原因。